Author Login IJIRT Partner Network (IPN) Login

Review on pulmonary devices, Respiratory disorders and Management

  • Unique Paper ID: 166614
  • Volume: 11
  • Issue: 2
  • PageNo: 1690-1696
  • Abstract:
  • Pulmonary drug delivery systems represent a pivotal advancement in the treatment of respiratory diseases, offering direct medication administration to the lungs for conditions such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. These systems provide several advantages, including rapid onset of action, local targeting with high drug concentrations, and reduced systemic side effects. The primary types of pulmonary delivery devices include metered dose inhalers (MDIs), dry powder inhalers (DPIs), and nebulizers, each with unique mechanisms and specific use cases. Emerging technologies, such as smart inhalers and nanoparticle-based systems, are enhancing delivery efficacy and patient adherence. Key considerations for effective pulmonary drug delivery involve optimizing particle size for deep lung deposition, ensuring formulation stability, and designing user-friendly devices. With ongoing research and technological advancements, pulmonary drug delivery continues to improve therapeutic outcomes and patient quality of life in respiratory disease management.
Download article email to a friend

Cite This Article

  • ISSN: 2349-6002
  • Volume: 11
  • Issue: 2
  • PageNo: 1690-1696

Review on pulmonary devices, Respiratory disorders and Management

Related Articles

Impact Factor
8.01 (Year 2024)
UGC Approved
Journal no 47859

Join Our IPN

IJIRT Partner Network

Submit your research paper and those of your network (friends, colleagues, or peers) through your IPN account, and receive 800 INR for each paper that gets published.

Join Now

Latest Publication

Archive

View More

Recent Conferences

NCSEM 2024

National Conference on Sustainable Engineering and Management - 2024 Last Date: 15th March 2024

Submit inquiry